Victory Capital Management
AYTU icon

Victory Capital Management’s AYTU BioPharma AYTU Stock Holding History

Victory Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-85
Closed -$20K – 2539
2020
Q3 		$20K Sell
85
-5
-6% -$1.28K ﹤0.01% 2435
2020
Q2 		$26K Sell
90
-69
-43% -$20.9K ﹤0.01% 2432
2020
Q1 		$48K Buy
+159
New +$30.7K ﹤0.01% 2772
2019
Q4 		– Sell
-15
Closed -$4K – 2695
2019
Q3 		$4K Buy
+15
New +$4.52K ﹤0.01% 3492

Other funds holding AYTU

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Victory Capital Management's AYTU Position: Q4 2020 in Review

Victory Capital Management sold out of AYTU BioPharma (AYTU) in Q4 2020, closing a stake of 85 shares — an estimated $20K sold.

Victory Capital Management first reported a position in AYTU in Q3 2019 and held it in 4 quarters. The position peaked at $48K in Q1 2020. 42 funds tracked by Wall St. Rank hold AYTU as of Q4 2020.

  • Victory Capital Management reported no remaining AYTU BioPharma position as of Q4 2020 after selling out during the quarter.
  • Victory Capital Management sold 85 AYTU BioPharma shares in Q4 2020, an estimated $20K.
  • Victory Capital Management first reported a position in AYTU BioPharma in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's AYTU BioPharma position peaked at $48K in Q1 2020.
  • 42 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2020.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.